Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells

BACKGROUND: Hepatocellular carcinoma (HCC) still is a big burden for China. In recent years, the third-generation platinum compounds have been proposed as potential active agents for HCC. However, more experimental and clinical data are warranted to support the proposal. In the present study, the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Qiong, Qin, Shu-Kui, Teng, Feng-Meng, Chen, Chang-Jie, Wang, Rui
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988698/
https://www.ncbi.nlm.nih.gov/pubmed/21034513
http://dx.doi.org/10.1186/1756-8722-3-43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988698/
https://www.ncbi.nlm.nih.gov/pubmed/21034513
http://dx.doi.org/10.1186/1756-8722-3-43

Ejemplares similares